Cell & Gene Therapy Market Report 2026-2036: 17.3% CARG
7 April 2026.
The global cell & gene therapy market is projected to grow at a CAGR of 17.3% by 2036
Healthcare & Pharma
The Race to Own Alzheimerโs: New Therapies Reshape Market
1 April 2026.
Alzheimerโs shifts to early intervention, with innovation reshaping competitive dynamics.
Decentralised Clinical Trials: From Adoption to Execution Risk
25 March 2026.
Decentralised trials shift from adoption to execution as complexity rises
Global Decentralised Clinical Trials Market 2026-2036: CAGR 11.5%
23 March 2026.
The global decentralised clinical trials market is projected to grow at a CAGR of 11.5% by 2036
Rheumatoid Arthritis Is Entering a New Competitive Phase
18 March 2026.
RA market shifting beyond biologics, driven by access, innovation, and pricing
The GLP-1 Boom: A Drug Class Redefining the Obesity Market
13 March 2026.
GLP-1 therapies are transforming obesity treatment and reshaping the global pharmaceutical market
Precision Payloads: The Rise of Antibody Drug Conjugates in Modern Oncology
4 March 2026.
Antibody drug conjugates are reshaping oncology through precision targeting, expanding pipelines and industry partnerships
Durability and Delivery: How Biologics Are Redefining Ophthalmology
25 February 2026.
Ophthalmology shifts to durable growth through biologics, delivery innovation and consolidation.
Biologic Innovation to Driveย Global Ophthalmic Drugs at 7.9% CAGR
17 February 2026.
Ophthalmics offers durable growth amid broader pharma market volatility
Fill-Finish Manufacturing Is Now a Strategic Constraint
11 February 2026.
Fill-finish capacity now defines biologics launches, valuation strength, and competitive leverage
Longevity Market to Grow at 8.6% CAGR as Institutional Adoption Accelerates
9 February 2026.
The global Longevity market is projected to grow at a CAGR of 8.6% by 2036
Alzheimer’s Therapeutics Market to Grow at 18.2% CAGR as Access Frameworks Evolve
6 February 2026.
The global Alzheimerโs Therapeutics market is projected to grow at a CAGR of 18.2% by 2036
Drug Discovery Outsourcing as Strategy: ROI, Agility, and Advantage
4 February 2026.
Drug discovery outsourcing reshapes pipeline speed, capital efficiency, and competitive advantage
Pharma Wholesale Distribution as Strategy: Access, Scale, and Value
28 January 2026.
Pharma distribution is becoming a strategic lever shaping access, affordability, scale.
Anti-obesity Drugs Market Set to Soar at 24.2% CAGR as GLP-1 Therapies Drive Expansion
27 January 2026.
The global Anti-obesity Drugs market 2026-2036 is projected to grow at a CAGR of 24.2% by 2036
Clinical Trial Supply & Logistics: When Execution Risks Delivery
21 January 2026.
Clinical trial supply chains have become strategic engines of feasibility, resilience, and value.
Rheumatoid Arthritis Drugs Market
20 January 2026.
The global Rheumatoid Arthritis market is projected to grow at a CAGR of 4.6% by 2036
Precision at Scale: The Business of Genome Editing
14 January 2026.
Genome editing shifts toward execution as CRISPR matures, partnerships scale delivery, manufacturing, regulatory readiness.
Vaccine Contract Manufacturing Market: Execution Now Defines Competitive Advantage.
12 January 2026.
The global Vaccine Contract Manufacturing market is projected to grow at a CAGR of 10.9% by 2036
Cold Chain Logistics: Building Resilient Healthcare Systems
7 January 2026.
Cold chain logistics becomes strategic infrastructure, enabling biologics, vaccines, advanced therapies at global scale.
